Corporate egg freezing: Why global leaders act while India stays silent

In the international battle for top talent, workplace benefits have steadily expanded beyond health insurance and bonuses into territory once thought unimaginable. From fully paid parental leave to fertility treatments, companies are exploring every possible advantage to retain skilled employees. Among the most controversial and high-profile of these is corporate-funded egg freezing.

Apple and Facebook first shook the corporate world in 2014 when they announced they would cover the cost of elective egg freezing for employees. Facebook offered up to $20,000 as part of its surrogacy benefit, while Apple included it under a fertility benefit beginning in 2015. The idea was simple but radical: empower women to delay childbearing if they wished, without fearing diminished fertility.

The move set off a wave of adoption across the US corporate landscape. Google, Yahoo, Netflix, Citigroup, JP Morgan Chase and Microsoft soon followed suit. Consulting firm Mercer found that in 2023, 19% of large US companies offered non-medical egg-freezing coverage, up from 16% in 2022, with rates higher in tech and finance. By 2024, Mercer reported that 21% of large employers covered elective egg freezing and 20% covered sperm freezing.

A slower but steady uptake

While the US leads, Europe has cautiously embraced the benefit. In the UK, employers such as NatWest, Centrica, and law firms Clifford Chance and Cooley provide fertility support, including egg freezing subsidies. The UK fertility regulator HFEA notes that the average cost for freezing and thawing eggs is £7,000 to £8,000, often rising with multiple cycles.

Elsewhere, Swiss pharmaceutical giant Merck and Swedish music streaming company Spotify have included egg freezing in family-forming benefits. Spotify’s global programme, launched in 2021, allows staff to claim for IVF, donor services, adoption and fertility preservation. “The allowance can cover several IVF cycles,” said HR chief Katarina Berg in an interview with Euronews.

The benefit is not without criticism. The Financial Times has noted concerns that women might feel pressured to delay parenthood for career reasons, raising questions about whether “choice” is genuinely free when tied to workplace culture. The New Yorker has also cautioned against over-promising, describing egg freezing as “a source of hope, not a guarantee”.

Anthropologist Marcia C. Inhorn, in her book Motherhood on Ice, found that women often froze eggs not primarily for career reasons, but because they lacked stable partners. This nuance suggests that the decision is deeply personal—and employers must tread carefully to avoid turning a benefit into a subtle expectation.

Employee perspectives: Hope and hesitation

Away from boardrooms, the real impact of such policies is playing out in the lives of employees. On forums like Reddit and Glassdoor, women share experiences that show both the promise and the dilemmas of egg-freezing perks.

On the subreddit r/eggfreezing, one health tech professional wrote about the financial strain of fertility treatment. Despite being in her twenties, she was diagnosed with diminished ovarian reserve and had already undergone four retrievals—entirely out of pocket. “I’ve hit my financial max, and my doctor recommends another cycle in the next three months,” she posted, adding that she was actively job-hunting at firms offering fertility coverage because her current insurance didn’t include egg freezing. 

On Glassdoor’s Women in Consulting community, another user described being torn about whether to use her company’s egg-freezing subsidy. While her employer offered partial cost coverage as a taxable benefit, she worried about the long-term financial implications of storage fees—around £1,400 a year—and whether she even wanted children at all. At 30, she wrote, she still had time but was unsure if freezing her eggs was the right step (Glassdoor discussion).

These testimonies highlight a central tension: while coverage reduces financial barriers, egg freezing is still a deeply personal decision filled with uncertainty, costs and emotional weight.

And India? Silence.

While global leaders frame egg freezing as a progressive benefit, India’s corporate sector has largely stayed silent. No major Indian company has publicly announced elective egg-freezing coverage, and conversations remain confined to online forums, private clinics, and niche advocacy circles.

India has a booming IVF and fertility industry, with clinics offering egg freezing at costs ranging from ₹1.5 lakh to ₹5 lakh per cycle. Yet employer involvement is virtually absent. Fertility coverage, when available, is usually restricted to IVF treatments under health insurance add-ons, not elective preservation.

Social stigma also plays a role. Discussions around reproductive autonomy remain culturally sensitive, and many Indian firms may be reluctant to openly back policies that could be perceived as encouraging women to delay motherhood.

This silence contrasts with India’s ambitions as a global talent hub. As multinational companies integrate reproductive benefits into their global policies, Indian arms of these firms may eventually have to follow. But without local corporate champions, the issue risks remaining invisible.

For Indian women professionals, the lack of conversation creates barriers. With more women entering higher education and pursuing careers, the pressure of biological timelines remains acute. Without employer support, egg freezing remains a privilege of the wealthy.